Inaugural NYC Pancreatic Cancer Consortium

Statement of Need: The morbidity and mortality of cancer is still a public health crisis. Pancreatic cancer, in particular, has one of the worst survival rates. Increased knowledge of new treatment methodologies, new research being done in the disease and how to best care for the patient with Pancreas cancer are vitally important to improving the survival rate of patients with pancreatic cancer. Each year more and more research is being done in pancreatic cancer requiring physicians and advanced clinical providers to have knowledge of new medications used to treat the disease. New to cancer diagnosis and treatment is the use of molecular biology and genetic testing. It has been found that different molecular abnormalities of pancreatic cancer react differently to different medications to treat pancreatic cancer. Providing our learners with the extensive knowledge of molecular and genetic testing in correlation to the appropriate therapy to treat a pancreatic patient is of utmost importance. This conference will provide the opportunity for participants to increase their knowledge and competencies in the care and management of pancreatic cancer

Target Audience: This activity was planned by and for MDs, and PAs. All other members of the healthcare team who are interested in the field of Pancreatic Cancer, NPs, RNs, Residents, Fellows, Medical Students, and Northwell Retirees are invited to attend.

Program Objectives: All Northwell Health CME activities are intended to improve patient care, safety, and outcomes. At the conclusion of this conference participants should be able to:

– Review and analyze advances in the treatment of pancreatic cancer including newly available clinical trials...

– Identify specific clinical trials available to pancreatic cancer patients at different stages of the disease process.

– Describe specific mutations found in patients with pancreatic cancer that would indicate use of a specific Medic*tion to treat the disease

Joint Accreditation Statement: In support of improving patient care, Northwell Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Ph*rm*cy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team

Credit Designation Statements

Physicians: Northwell Health designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Nurses: Northwell Health designates this activity for 5.5 ANCC contact hours

Physician Assistants: Northwell Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation

Verification of Attendance: This will be provided to all professionals.

Disclosure Policy: Northwell Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible companies. All relevant conflicts of interest will be mitigated prior to the commencement of the activity.

Registration Fee Includes: Live and On-Demand Session for educational purposes only for the next 30 days and CME/Verification of attendance certificates.

Americans With Disabilities Act:

This conference is in compliance with provisions of the Americans with Disabilities Act (ADA) and is accessible for individuals with special needs. If you would like to attend this conference and require any special needs or accommodations, please contact us at(516) 321 8353

Host or Publisher Northwell Health Cancer Institute